Insulet | 销售和管理费用



Selling And Administration Expenses 更改 日
Abbott USD 3.05B 144M 2025-03
Align Technology USD 447.63M 22.66M 2025-03
AtriCure USD 76.05M 3.87M 2025-03
Avanos Medical USD 79.6M 6.9M 2024-12
Baxter International USD 615M 16M 2024-12
Becton, Dickinson and Co. USD 1.32B 62M 2024-12
Boston Scientific USD 1.6B 15M 2025-03
Cardinal Health USD 1.31B 29M 2024-12
Cooper Companies USD 387.9M 3.5M 2025-01
Dexcom USD 327.4M 21M 2024-12
Edwards Lifesciences USD 465.7M 26.2M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Globus Medical USD 253.48M 12.74M 2024-12
ICU Medical USD 158.54M 3.88M 2024-12
Insulet USD 261M 26.9M 2024-12
Integra LifeSciences USD 169.62M 5.48M 2024-12
J&J USD 5.11B 1.34B 2025-03
Masimo USD 223.4M 38.6M 2024-12
Medtronic USD 2.72B 34M 2025-01
Merit Medical Systems USD 107.49M 4.91M 2025-03
Roche Holding CHF 3.61B 381M 2024-12
Solventum Corp 784M 83M 2024-12
Stryker USD 2.03B 229M 2024-12
Tandem Diabetes Care USD 104.97M 871K 2025-03
Teleflex USD 222.71M 31.84M 2025-03
West Pharmaceutical Services USD 88M 2.7M 2025-03
Zimmer Biomet Holdings USD 724.7M 18.8M 2024-12



Insulet 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.